Amyotrophic lateral sclerosis, ALS for short, is a mysterious neurodegenerative disease that is almost always fatal. A consortium of researchers has systematically investigated the underlying molecular mechanisms of ALS. Among other things, the team discovered that ALS can be divided into subtypes. Depending on the subtype, different drugs could be effective. There are also clear differences in the molecular processes when comparing men and women. Furthermore, the researchers identified a promising target for new drugs against ALS.
The molecular processes in the body that cause ALS patients to increasingly lose control of motor functions are still poorly understood. Previous studies have been limited to individual aspects of the underlying molecular processes. A consortium has investigated ALS using a so-called "multi-omics" approach. The researchers mapped both coding and non-coding RNA molecules and the entirety of the proteins.
A key finding of the study is that ALS can be roughly divided into four subtypes. "You can't distinguish between these variants based on the clinical symptoms," says the author. "However, very different things happen at the molecular level. This means that an active substance that is ineffective in one ALS subtype may well be helpful in another. Previous clinical studies could only look at the effects across all patients and may not have identified substances effective for an individual subtype."
While in one common subtype genes associated with inflammatory processes and immune responses were affected, in another there were mainly disturbances in the transcription of DNA into RNA molecules. In two others, different signs of oxidative stress were found in the cells. The researchers assume that the ALS subtype may change over the course of the disease.
Men develop ALS around 1.2 times more frequently than women. The breakdown of the molecular processes also revealed clear differences between the sexes. While the four subtypes appear to occur equally frequently in both sexes, the researchers found a significantly larger number of altered gene products in men. From the researchers' point of view, this could mean that men and women will have to be treated differently in future.
Through the multi-omics analysis, the researchers also identified a signaling pathway that could be a particularly suitable target for new drugs against ALS. "This signaling pathway, MAPK, is well described in neurobiology and plays a role in various, although by no means all, processes in ALS," says a co-last author of the study. From the researchers' point of view, it would therefore be promising to repurpose an approved cancer drug that acts on MAPK for ALS.
The study is based on tissue samples from deceased ALS patients and additional investigations using mouse models of the disease. "An important next step is to find a way to determine the ALS subtype of patients while they are still alive - we are currently working on this," says the author. "We believe that our study made an important contribution to the search for causes and therapies for ALS. Our findings have brought us a good deal closer to a more personalized and, therefore, more effective therapy."
Latest News
Molecular mechanisms of som…
By newseditor
Posted 01 Jul
A distinct macrophage popul…
By newseditor
Posted 30 Jun
Sex differences in neurolog…
By newseditor
Posted 30 Jun
A neutralizing antibody blo…
By newseditor
Posted 30 Jun
Novel epigenic editor, CHAR…
By newseditor
Posted 30 Jun
Other Top Stories
Gut cells that slow down metabolism and accelerate cardiovascular d…
Researchers have discovered how specific cells in the guts of mice slow down metabolism and eventually contribute to obesity, diabetes, hypertension and atherosclerosis. The findings appears in the journal Nature, scientists say, could have important implications for the prevention and treatment of these kinds of metabolic diseases in humans.
"With this research we are connecting the dots between…
Read more
Widespread RNA editing changes in patients with autism
Read more
Role of immune cells in relieving pain after peripheral neuropathy
Read more
Vitamin D could lower the risk of developing diabetes
Read more
Flipping behavior under threat
Read more
Protocols
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Publications
Monitoring melanoma patient…
By newseditor
Posted 30 Jun
Loss of GPR75 protects agai…
By newseditor
Posted 30 Jun
Effects of evening smartpho…
By newseditor
Posted 30 Jun
Antibody-activation of conn…
By newseditor
Posted 30 Jun
Mechanism of chaperone coor…
By newseditor
Posted 29 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar